Drugs

Development and Regulation of Abuse-Deterrent Opioid Medications – FDA Public Meeting

The FDA is hosting a public meeting on October 30 and 31, 2014 to discuss the development, assessment, and regulation […]

By R Kennedy | Drugs . FDA . Opioids . Substance abuse

DETAIL

Sixth Annual Chair Summit Begins This Week

This week a Master Class for Neuroscience Development called the Chair Summit takes place in Tampa, FL (Sept 26-28, 2013). […]

By R Kennedy | Addiction . ADHD . Antipsychotic medication . Anxiety Disorders . Biomarker . Bipolar Disorder . Cardiovascular Risk Factors . Chronic Pain . CME . Dementia . Depression . Diabetes . Diagnosis . Digital medicine . Drug Development . Drugs . DSM-5 . Early intervention . Education . Food . Genetics . Guideline . Imaging . Maintenance of Certification . Measurement-based care . Medical Education . Mood . MRI . Multiple sclerosis . Negative symptoms . Neuroscience . Obesity . Opioids . PET . Practice guideline . Psychosis . PTSD . Research . Schizophrenia . Smoking cessation . Social media . Stroke . Substance abuse . Transcranial magnetic stimulation . Vascular dementia

DETAIL

New report sheds light on adolescent substance use

According to a report published yesterday by SAMHSA, the number of teenagers from age 12 to 17 smoke cigarettes on a […]

By R Kennedy | Adolescents . Drugs . Opioids . Substance abuse . Uncategorized

DETAIL

FDA Offers Draft Guidance on Abuse-deterrent Opioids

The U.S. Food and Drug Administration today issued a draft guidance document to assist industry in developing new formulations of […]

By R Kennedy | Addiction . Drugs . News . Opioids

DETAIL